Kelly Blackburn Appointed Bach Pharma CEO
July 18, 2016
Bach Pharma Inc. (North Andover, MA) has appointed Kelly Blackburn as Chief Executive Officer.
Kelly Blackburn
Ms. Blackburn was previously Vice President of Clinical Affairs at aTyr Pharma (San Diego, CA). Prior to that she was at Vertex Pharmaceuticals.
Ms. Blackburn is tasked with leading Bach Pharma as it brings its lead candidate, GVT, into the clinic.
The company also announced that Mark O. Henry will serve as Chief Financial Officer, transitioning from his role as CEO.
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
